- Home
- OSW vs ARQT Comparison
OSW vs ARQT Comparison
Compare OSW & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | ARQT |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Bahamas | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.2B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OSW | ARQT |
|---|---|---|
| Price | $22.70 | $25.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $31.20 | ★ $37.00 |
| AVG Volume (30 Days) | 791.6K | ★ 2.4M |
| Earning Date | 10-28-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ 88.79 |
| EPS | ★ 0.44 | 0.03 |
| Revenue | ★ $961,001,000.00 | $376,072,000.00 |
| Revenue This Year | $7.61 | $42.88 |
| Revenue Next Year | $8.69 | $27.84 |
| P/E Ratio | ★ $52.08 | $899.67 |
| Revenue Growth | 7.37 | ★ 91.34 |
| 52 Week Low | $19.06 | $19.30 |
| 52 Week High | $29.25 | $31.77 |
Technical Indicators
Market Signals| Indicator | OSW | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 53.37 |
| Support Level | $20.95 | $24.91 |
| Resistance Level | $23.55 | $28.20 |
| Average True Range (ATR) | 0.59 | 1.44 |
| MACD | 0.21 | 0.16 |
| Stochastic Oscillator | 50.71 | 62.81 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.